Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines

被引:118
作者
Burlison, Joseph A. [1 ]
Avila, Christopher [2 ]
Vielhauer, George [2 ]
Lubbers, Donna J. [1 ]
Holzbeierlein, Jeffrey [2 ]
Blagg, Brian S. J. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66160 USA
关键词
D O I
10.1021/jo702191a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Recent studies have shown that the DNA gyrase inhibitor, novobiocin, binds to a previously unrecognized ATP-binding site located at the C-terminus of Hsp90 and induces degradation of Hsp90-dependent client proteins at similar to 700 mu M. As a result of these studies, several analogues of the coumarin family of antibiotics have been reported and shown to exhibit increased Hsp90 inhibitory activity; however, the monomeric species lacked the ability to manifest anti-proliferative activity against cancer cell lines at concentrations tested. In an effort to develop more efficacious compounds that produce growth inhibitory activity against cancer cell lines, structure-activity relationships; were investigated surrounding the prenylated benzamide side chain of the natural product. Results obtained from these studies have produced the first novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.
引用
收藏
页码:2130 / 2137
页数:8
相关论文
共 51 条
[1]   A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicity [J].
Ansar, Sabah ;
Burlison, Joseph A. ;
Hadden, M. Kyle ;
Yu, Xiao Ming ;
Desino, Kelly E. ;
Bean, Jennifer ;
Neckers, Len ;
Audus, Ken L. ;
Michaelis, Mary L. ;
Blagg, Brian S. J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :1984-1990
[2]   4-amino derivatives of the Hsp90 inhibitor CCT018159 [J].
Barril, X ;
Beswick, MC ;
Collier, A ;
Drysdale, MJ ;
Dymock, BW ;
Fink, A ;
Grant, K ;
Howes, R ;
Jordan, AM ;
Massey, A ;
Surgenor, A ;
Wayne, J ;
Workman, P ;
Wright, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) :2543-2548
[3]   Structure-based discovery of a new class of Hsp90 inhibitors [J].
Barril, X ;
Brough, P ;
Drysdale, M ;
Hubbard, RE ;
Massey, A ;
Surgenor, A ;
Wright, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (23) :5187-5191
[4]   Orally active purine-based inhibitors of the heat shock protein 90 [J].
Biamonte, MA ;
Shi, JD ;
Hong, K ;
Hurst, DC ;
Zhang, L ;
Fan, JH ;
Busch, DJ ;
Karjian, PL ;
Maldonado, AA ;
Sensintaffar, JL ;
Yang, YC ;
Kamal, A ;
Lough, RE ;
Lundgren, K ;
Burrows, FJ ;
Timony, GA ;
Boehm, MF ;
Kasibhatla, SR .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :817-828
[5]   Hsp90: A novel target for the disruption of multiple signaling cascades [J].
Bishop, Stephanie C. ;
Burlison, Joseph A. ;
Blagg, Brian S. J. .
CURRENT CANCER DRUG TARGETS, 2007, 7 (04) :369-388
[6]   Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation [J].
Blagg, BSJ ;
Kerr, TA .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (03) :310-338
[7]   3-(5-chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone [J].
Brough, PA ;
Barril, X ;
Beswick, M ;
Dymock, BW ;
Drysdale, MJ ;
Wright, L ;
Grant, K ;
Massey, A ;
Surgenor, A ;
Workman, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (23) :5197-5201
[8]   Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery [J].
Burlison, Joseph A. ;
Blagg, Brian S. J. .
ORGANIC LETTERS, 2006, 8 (21) :4855-4858
[9]   Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90 [J].
Burlison, Joseph A. ;
Neckers, Len ;
Smith, Andrew B. ;
Maxwell, Anthony ;
Blagg, Brian S. J. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (48) :15529-15536
[10]   Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90 [J].
Chadli, A ;
Bouhouche, I ;
Sullivan, W ;
Stensgard, B ;
McMahon, N ;
Catelli, MG ;
Toft, DO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12524-12529